![Richard Cunningham](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Richard Cunningham
Vorstandsvorsitzender bei
ANEBULO PHARMACEUTICALS, INC.
Vermögen: - $ am 31.07.2026
Profil
Richard Anthony Cunningham currently works at Anebulo Pharmaceuticals, Inc., as Chief Executive Officer & Director from 2023.
Mr. Cunningham also formerly worked at Icagen, Inc., as President, Chief Executive Officer & Director in 2020, Icagen-T, Inc., as President, Chief Executive Officer & Director from 2014 to 2020, and Tyme Technologies, Inc., as Chief Executive Officer & Director.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 26.09.2025 | 0 ( -.--% ) | - $ | 31.07.2026 |
Aktive Positionen von Richard Cunningham
| Unternehmen | Position | Beginn |
|---|---|---|
| ANEBULO PHARMACEUTICALS, INC. | Vorstandsvorsitzender | 06.10.2023 |
Ehemalige bekannte Positionen von Richard Cunningham
| Unternehmen | Position | Ende |
|---|---|---|
| TYME TECHNOLOGIES, INC. | Vorstandsvorsitzender | 01.10.2022 |
Icagen-T, Inc.
 Icagen-T, Inc. BiotechnologyHealth Technology Engages in development of pharmaceutical drugs for therapeutic needs | Vorstandsvorsitzender | 20.11.2020 |
Icagen, Inc.
 Icagen, Inc. Medical SpecialtiesHealth Technology Develops pharmaceutical and drug discovery instruments | Vorstandsvorsitzender | 01.11.2020 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
31
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Icagen, Inc.
Icagen, Inc. Medical SpecialtiesHealth Technology Develops pharmaceutical and drug discovery instruments | Health Technology |
Tyme Technologies, Inc.
 Tyme Technologies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops cancer metabolism-based therapeutics | Health Technology |
Icagen-T, Inc.
Icagen-T, Inc. BiotechnologyHealth Technology Engages in development of pharmaceutical drugs for therapeutic needs | Health Technology |
Anebulo Pharmaceuticals, Inc.
 Anebulo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
